The Global Smart Pills Market is segmented on the basis of applications and regions.

SMART PILLS MARKET
By Application (Capsule Endoscopy, Drug Delivery,
Patient Monitoring), Target Area (Stomach, Small Intestine,
Large Intestine) & Geography
sales@marketsandmarkets.com Report Code: MD 3264
GLOBAL FORECAST TO 2024

2
Smart Pills Market – Global Forecast to 2024
© MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish
strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500
companies across the world. MarketsandMarkets also provides multi-client reports, company profiles,
databases, and custom research services.
MarketsandMarkets covers fourteen industry verticals, including aerospace and defence, advanced
materials, automotives and transportation, biotechnology, chemicals, consumer goods, energy and power,
food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and
electronics, and telecommunications and IT.
Copyright © 2015 MarketsandMarkets
All Rights Reserved. This document contains highly confidential information and is the sole property of
MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the
approval of MarketsandMarkets.

3
TABLE OF CONTENTS
1 INTRODUCTION........................................................................................................ 13
1.1 OBJECTIVES OF THE STUDY...........................................................................................................13
1.2 MARKET DEFINITION.....................................................................................................................13
1.3 MARKET SCOPE............................................................................................................................14
1.3.1 MARKETS COVERED.......................................................................................................14
1.3.2 YEARS CONSIDERED FOR THE STUDY..............................................................................15
1.4 CURRENCY & PRICING..................................................................................................................15
1.5 LIMITATIONS ................................................................................................................................15
1.6 STAKEHOLDERS...........................................................................................................................16
2 RESEARCH METHODOLOGY...................................................................................... 17
2.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY................................................................18
2.1.1 SECONDARY RESEARCH.................................................................................................18
2.1.2 KEY DATA FROM SECONDARY SOURCES.........................................................................18
2.1.3 PRIMARY RESEARCH......................................................................................................19
2.1.3.1 Key data from primary sources...........................................................................20
2.1.3.2 Key insights from primary sources......................................................................21
2.2 MARKET SIZE ESTIMATION METHODOLOGY ...................................................................................21
2.2.1 MARKET FORECAST METHODOLOGY ...............................................................................23
2.2.2 MARKET DATA VALIDATION AND TRIANGULATION............................................................23
2.2.3 ASSUMPTIONS FOR THE STUDY ......................................................................................24
3 EXECUTIVE SUMMARY.............................................................................................. 25
4 PREMIUM INSIGHTS ................................................................................................ 29
4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE SMART PILLS MARKET .............................................29
4.2 GLOBAL SMART PILLS MARKET, BY APPLICATION..........................................................................30
4.3 GROWTH RATE ACROSS GEOGRAPHIES.........................................................................................31
4.4 SMART PILLS MARKET: LIFE CYCLE ANALYSIS, BY GEOGRAPHY......................................................32
5 MARKET OVERVIEW.................................................................................................. 33
5.1 INTRODUCTION ............................................................................................................................34
5.2 MARKET SEGMENTATION..............................................................................................................34
5.2.1 SMART PILLS MARKET, BY APPLICATION.........................................................................34
5.2.2 SMART PILLS MARKET, BY GEOGRAPHY..........................................................................35
5.3 MARKET DYNAMICS......................................................................................................................36

4
5.4 DRIVERS ......................................................................................................................................36
5.4.1 FAVORABLE REIMBURSEMENT SCENARIO......................................................................36
5.4.2 PATIENT PREFERENCE FOR MINIMALLY INVASIVE SURGERIES.........................................37
5.4.3 TECHNOLOGICAL ADVANCEMENTS IN CAPSULE ENDOSCOPES .......................................37
5.4.4 INCREASE IN INCIDENCE OF COLON CANCER .................................................................37
5.4.5 BOWEL SCOPE SCREENING IS EXPECTED TO HAVE A POSITIVE IMPACT ON
THE ENDOSCOPY MARKET IN THE U.K. ............................................................................39
5.4.6 GROWTH IN AGING POPULATION.....................................................................................40
5.5 RESTRAINTS.................................................................................................................................41
5.5.1 TECHNOLOGICAL LIMITATIONS IN TERMS OF TAKING IMAGES OF A
PARTICULAR SITE AND RETENTION OF CAPSULE .............................................................41
5.5.2 INCREASING TECHNOLOGICAL SOPHISTICATION IN SMART PILLS TO
INCREASE THEIR COST ...................................................................................................42
5.6 OPPORTUNITIES...........................................................................................................................42
5.6.1 NEED FOR A RAPID DRUG DEVELOPMENT PROCESS .......................................................42
5.7 PORTER’S FIVE FORCES ANALYSIS................................................................................................43
5.7.1 THREAT OF NEW ENTRANTS ............................................................................................44
5.7.2 THREAT OF SUBSTITUTES................................................................................................44
5.7.3 BARGAINING POWER OF BUYERS ...................................................................................44
5.7.4 BARGAINING POWER OF SUPPLIERS ..............................................................................45
5.7.5 INTENSITY OF COMPETITIVE RIVALRY ..............................................................................45
6 SMART PILLS TECHNOLOGY MARKET, BY APPLICATION............................................. 46
6.1 INTRODUCTION ............................................................................................................................47
6.2 CAPSULE ENDOSCOPES...............................................................................................................48
6.2.1 OVERVIEW......................................................................................................................48
6.2.2 CAPSULE ENDOSCOPES: COMPONENTS.........................................................................48
6.2.2.1 Components .....................................................................................................49
6.2.3 PILLCAM COLON BY GIVEN IMAGING ..............................................................................50
6.2.3.1 Interactive colon exam comparison tool .............................................................51
6.2.4 CURRENTLY MARKETED PRODUCTS WITH SPECIFICATIONS.............................................52
6.2.5 CAPSULE ENDOSCOPES MARKET SIZE............................................................................53
6.3 SMART PILLS FOR PATIENT MONITORING......................................................................................56
6.3.1 SMART PILLS FOR PATIENT MONITORING: OVERVIEW......................................................56
6.3.2 PROTEUS DIGITAL HEALTH..............................................................................................56
6.3.3 SMART PILLS FOR PATIENT MONITORING: MARKET SIZE..................................................57
6.3.4 SMART PILLS FOR PATIENT MONITORING: FUTURE POTENTIAL.........................................57
6.4 SMART PILLS FOR DRUG DELIVERY...............................................................................................58
6.4.1 SMART PILLS FOR DRUG DELIVERY: OVERVIEW...............................................................58
6.4.2 INTELLICAP SYSTEM BY MEDIMETRICS ...........................................................................58
6.4.3 SMART PILLS FOR DRUG DELIVERY: MARKET SIZE...........................................................59
6.4.4 SMART PILLS FOR DRUG DELIVERY: FUTURE POTENTIAL..................................................60

5
7 RESEARCH LANDSCAPE........................................................................................... 61
7.1 THE MELODY PROJECT..................................................................................................................61
7.2 EDIBLE BATTERY TO TARGET HEALTH SENSORS AND DRUG DELIVERY............................................62
7.3 LASER PILL FOR ESOPHAGUS IMAGING ........................................................................................62
7.4 MAARS REMOTE-CONTROLLED MAGNETIC CAPSULE.....................................................................63
7.5 DESIGN AND IMPLEMENTATION OF MINIATURIZED CAPSULES FOR AUTO-
FLUORESCENCE DETECTION WITH POSSIBLE APPLICATIONS IN BOWEL DISEASE...........................63
7.6 DETECTING A SECRETED GASTRIC CANCER BIOMARKER MOLECULE BY TARGETED
NANOPARTICLES FOR REAL-TIME DIAGNOSTICS ...........................................................................64
7.7 MAGNETICALLY ACTUATED SOFT CAPSULE ENDOSCOPE (MASCE) .................................................65
7.8 POWER GENERATION TECHNOLOGY USING BENDABLE THIN FILM NANO-MATERIALS.....................65
7.9 WIRELESSLY COMMUNICATING CAPSULE PROTOTYPE...................................................................66
7.10 DEVELOPMENT OF CMOS SENSORS FOR INCORPORATION IN ENDOSCOPIC CAPSULES
FOR CANCER CELLS .....................................................................................................................66
7.11 VERSATILE ENDOSCOPIC CAPSULE FOR GASTROINTESTINAL TUMOR RECOGNITION
AND THERAPY: VECTOR.................................................................................................................67
7.12 NOVEL, INNOVATIVE, REMOTE-CONTROLLED DRUG DELIVERY CAPSULE ........................................68
7.13 DRUG DELIVERY WITH MUSCLE.....................................................................................................68
8 SMART PILLS MARKET, BY REGION........................................................................... 69
8.1 INTRODUCTION ............................................................................................................................70
8.2 NORTH AMERICA..........................................................................................................................72
8.2.1 U.S. ...............................................................................................................................75
8.2.2 CANADA.........................................................................................................................76
8.3 EUROPE.......................................................................................................................................77
8.3.1 U.K. ...............................................................................................................................80
8.3.2 SPAIN............................................................................................................................81
8.3.3 GERMANY......................................................................................................................82
8.3.4 FRANCE .........................................................................................................................83
8.3.5 ITALY..............................................................................................................................84
8.3.6 REST OF EUROPE ...........................................................................................................86
8.4 ASIA.............................................................................................................................................87
8.4.1 JAPAN............................................................................................................................89
8.4.2 CHINA............................................................................................................................91
8.4.3 INDIA.............................................................................................................................92
8.4.4 REST OF ASIA (ROA) .......................................................................................................93
8.5 REST OF THE WORLD (ROW)..........................................................................................................94
8.6 PEST ANALYSIS ............................................................................................................................99
8.6.1 POLITICAL FACTORS.......................................................................................................99
8.6.2 ECONOMIC FACTORS .....................................................................................................99
8.6.3 SOCIAL FACTORS.........................................................................................................100
8.6.4 TECHNOLOGICAL FACTORS...........................................................................................100

6
9 COMPETITIVE LANDSCAPE ..................................................................................... 101
9.1 OVERVIEW..................................................................................................................................101
9.2 R&D INVESTMENT ANALYSIS, SMART PILLS MARKET...................................................................102
9.3 COMPETITIVE SITUATION AND TRENDS........................................................................................103
9.3.1 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS...............................................103
9.3.2 NEW PRODUCT LAUNCHES...........................................................................................104
9.4 EXPANSIONS..............................................................................................................................105
9.5 OTHER DEVELOPMENTS..............................................................................................................106
9.6 MERGERS AND ACQUISITIONS....................................................................................................106
10 COMPANY PROFILES.............................................................................................. 107
10.1 ACAMP.......................................................................................................................................108
10.1.1 BUSINESS OVERVIEW...................................................................................................108
10.1.2 ACAMP: COMPANY SNAPSHOT.....................................................................................108
10.1.3 PRODUCT PORTFOLIO...................................................................................................108
10.2 BIO-IMAGES RESEARCH LTD.......................................................................................................109
10.2.2 SERVICE OFFERINGS....................................................................................................109
10.2.3 RECENT DEVELOPMENTS..............................................................................................109
10.3 BOSTON SCIENTIFIC CORPORATION............................................................................................110
10.3.2 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT ..........................................110
10.3.3 KEY STRATEGY..............................................................................................................111
10.3.3.1 Focus on research and development: ...............................................................111
10.4 CAPSOVISION, INC.....................................................................................................................112
10.4.3 KEY STRATEGY..............................................................................................................113
10.4.3.1 Market development: ......................................................................................113
10.5 GIVEN IMAGING, INC. .................................................................................................................114
10.5.2 MEDTRONIC, INC.: COMPANY SNAPSHOT .....................................................................114
10.5.3 PRODUCT PORTFOLIO:..................................................................................................115
10.5.4 KEY STRATEGY..............................................................................................................115
10.5.4.1 FDA Approvals:................................................................................................115
10.6 MEDIMETRICS S.A. DE C.V..........................................................................................................116
10.6.2 PRODUCTS AND SERVICES...........................................................................................116
10.6.3 KEY STRATEGY..............................................................................................................116
10.6.3.1 Partnerships and collaborations: .....................................................................116

7
10.7 OLYMPUS CORPORATION ...........................................................................................................118
10.7.2 OLYMPUS CORPORATION: COMPANY SNAPSHOT..........................................................118
10.7.4 KEY STRATEGY..............................................................................................................119
10.7.4.1 New Product Launches ....................................................................................119
10.8 PROTEUS DIGITAL HEALTH, INC...................................................................................................120
10.8.3 KEY STRATEGY..............................................................................................................120
10.8.3.1 Partnerships and Collaborations......................................................................120
11 APPENDIX.............................................................................................................. 122
11.1 INSIGHTS OF INDUSTRY EXPERTS ...............................................................................................122
11.2 DISCUSSION GUIDE ...................................................................................................................123
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE.................................................................125
11.4 AVAILABLE CUSTOMIZATIONS.....................................................................................................125
11.5 RELATED REPORTS.....................................................................................................................126

8
LIST OF TABLES
UU
TABLE 1 INCREASING INCIDENCE OF THE CANCERS IN MEN GLOBALLY DRIVES THE SMART
PILL MARKET 38
TABLE 2 INCREASING INCIDENCE OF THE CANCERS IN WOMEN GLOBALLY DRIVES THE
SMART PILL MARKET 38
TABLE 3 COLORECTAL CANCER: ESTIMATED INCIDENCE, MORTALITY AND PREVALENCE
WORLDWIDE IN 2012 39
TABLE 4 COUNTRIES WITH HIGHEST INCIDENCE OF COLORECTAL CANCER IN 2012 (BOTH
SEXES) 40
TABLE 5 SMART PILLS MARKET SIZE, BY APPLICATION, 2014–2024 ($MILLION) 47
TABLE 6 SMART PILLS MARKET SIZE FOR CAPSULE ENDOSCOPES, BY REGION,
2014–2024 ($MILLION) 54
TABLE 7 CAPSULE ENDOSCOPES MARKET SIZE FOR SMALL INTESTINE, BY REGION,
2014-2024 ($MILLION) 54
TABLE 8 CAPSULE ENDOSCOPES MARKET SIZE FOR COLON, BY REGION,
2014-2024 ($ MILLION) 55
TABLE 9 CAPSULE ENDOSCOPES MARKET SIZE FOR OTHER CAPSULE ENDOSCOPY,
BY REGION, 2014-2024 ($ MILLION) 55
TABLE 10 SMART PILLS MARKET SIZE FOR PATIENT MONITORING, BY REGION,
2014–2024 ($MILLION) 57
TABLE 11 SMART PILLS MARKET SIZE FOR DRUG DELIVERY, BY REGION,
2014–2024 ($MILLION) 59
TABLE 12 SMART PILLS MARKET SIZE, BY REGION, 2012–2024 ($MILLION) 71
TABLE 13 NORTH AMERICA: SMART PILLS MARKET SIZE, BY APPLICATION,
2012–2024 ($MILLION) 73
TABLE 14 NORTH AMERICA: SMART PILLS MARKET SIZE, BY COUNTRY,
2012–2024 ($MILLION) 73
TABLE 15 NORTH AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY,
2012–2024 ($MILLION) 73
TABLE 16 NORTH AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 74
TABLE 17 NORTH AMERICA: DRUG DELIVERY MARKET SIZE, BY COUNTRY,
2012–2024 ($MILLION) 74
TABLE 18 NORTH AMERICA: PATIENT MONITORING MARKET SIZE, BY COUNTRY,
2012–2024 ($MILLION) 74
TABLE 19 US: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 75
TABLE 20 US: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 76
TABLE 21 CANADA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 76
TABLE 22 CANADA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 77
TABLE 23 EUROPE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 78
TABLE 24 EUROPE: SMART PILLS MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 78
TABLE 25 EUROPE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 78
TABLE 26 EUROPE: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY/REGION,
2014–2024 ($MILLION) 79

9
TABLE 27 EUROPE: DRUG DELIVERY MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 79
TABLE 28 EUROPE: PATIENT MONITORING MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 80
TABLE 29 UK: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 81
TABLE 30 UK: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 81
TABLE 31 SPAIN: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 82
TABLE 32 SPAIN: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 82
TABLE 33 GERMANY: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 83
TABLE 34 GERMANY: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 83
TABLE 35 FRANCE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 84
TABLE 36 FRANCE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 84
TABLE 37 ITALY: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 85
TABLE 38 ITALY: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 85
TABLE 39 ROE: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 86
TABLE 40 ROE: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 86
TABLE 41 ASIA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 87
TABLE 42 ASIA: SMART PILLS MARKET SIZE, BY COUNTRY/REGION, 2012–2024 ($MILLION) 87
TABLE 43 ASIA: CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 88
TABLE 44 ASIA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 88
TABLE 45 ASIA: DRUG DELIVERY MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 88
TABLE 46 ASIA: PATIENT MONITORING MARKET SIZE, BY COUNTRY/REGION,
2012–2024 ($MILLION) 89
TABLE 47 JAPAN: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 90
TABLE 48 JAPAN: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 90
TABLE 49 CHINA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 91
TABLE 50 CHINA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 91
TABLE 51 INDIA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 92
TABLE 52 INDIA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 92
TABLE 53 ROA: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 93
TABLE 54 ROA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 93
TABLE 55 ROW: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION) 94
TABLE 56 ROW: SMART PILLS MARKET SIZE, BY REGION, 2012–2024 ($MILLION) 95
TABLE 57 ROW: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 95
TABLE 58 ROW: CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2012–2024 ($MILLION) 95

10
TABLE 59 ROW: DRUG DELIVERY MARKET SIZE, BY REGION, 2012–2024 ($MILLION) 96
TABLE 60 ROW: PATIENT MONITORING MARKET SIZE, BY REGION, 2012–2024 ($MILLION) 96
TABLE 61 LATIN AMERICA: SMART PILLS MARKET SIZE, BY APPLICATION,
2012–2024 ($MILLION) 96
TABLE 62 LATIN AMERICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 97
TABLE 63 PACIFIC COUNTRIES: SMART PILLS MARKET SIZE, BY APPLICATION,
2012–2024 ($MILLION) 97
TABLE 64 PACIFIC COUNTRIES: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 97
TABLE 65 MIDDLE EAST & AFRICA: SMART PILLS MARKET SIZE, BY APPLICATION,
2012–2024 ($MILLION) 98
TABLE 66 MIDDLE EAST & AFRICA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA,
2012–2024 ($MILLION) 98
TABLE 67 AGREEMENTS AND COLLABORATIONS, 2012-2014 104
TABLE 68 NEW PRODUCT LAUNCHES, 2012-2014 104
TABLE 69 EXPANSIONS, 2012-2014 105
TABLE 70 OTHER DEVELOPMENTS, 2012-2014 106
TABLE 71 MERGERS AND ACQUISITIONS, 2012-2014 106
TABLE 72 EXCHANGE RATES (USED FOR CONVERSION OF YEN TO USD) 118

11
LIST OF FIGURES
FIGURE 1 SMART PILLS MARKET SEGMENTATION 14
FIGURE 2 RESEARCH METHODOLOGY DESIGN 17
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 20
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 22
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 22
FIGURE 6 MARKET FORECAST METHODOLOGY 23
FIGURE 7 DATA TRIANGULATION METHODOLOGY 24
FIGURE 8 ROW TO WITNESS THE HIGHEST GROWTH RATE IN THE CAPSULE ENDOSCOPY
MARKET FROM 2014 TO 2024 25
FIGURE 9 SMART PILLS MARKET SIZE, BY REGION(2014) 26
FIGURE 10 SMART PILLS MARKET SIZE, BY APPLICATION (2014 VS. 2024) 27
FIGURE 11 SMART PILLS MARKET TO GROW AT A CAGR OF 16% FROM 2014 TO 2020, CAGR
OF 23% FROM 2020 TO 2024 29
FIGURE 12 CAPSULE ENDOSCOPY SEGMENT COMMANDED THE LARGEST SHARE OF THE
GLOBAL SMART PILLS MARKET, 2014 30
FIGURE 13 ROW TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
(2020-2024) 31
FIGURE 14 ROW MARKET TO WITNESS HIGHEST GROWTH IN THE NEAR FUTURE(2020-2024) 32
FIGURE 15 SMART PILLS MARKET SEGMENTATION, BY APPLICATION 35
FIGURE 16 SMART PILLS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 36
FIGURE 17 PORTER’S FIVE FORCES ANALYSIS 43
FIGURE 18 CAPSULE ENDOSCOPES DOMINATION IN THE SMART PILLS MARKET IN
2014 VS 2020 53
FIGURE 19 ROW HAS HIGHEST GROWTH IN THE FORECASTED PERIOD 2014–2020
($MILLION) 59
FIGURE 20 NORTH AMERICAN MARKET TO WITNESS THE HIGHEST CAGR 70
FIGURE 21 CAPSULE ENDOSCOPY SEGMENT TO DOMINATE THE MARKET IN THE FORECAST
PERIOD 71
FIGURE 22 COMPANIES ADOPTED AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS AS
THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS 101
FIGURE 23 SMART PILLS MARKET: R&D EXPENDITURE SHARE, BY KEY PLAYER, 2014 102
FIGURE 24 BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, AND
COLLABORATIONS WAS THE KEY GROWTH STRATEGY 103
FIGURE 25 GEOGRAPHICAL PRESENCE OF THE TOP PLAYERS OF THE SMART PILLS MARKET 107

12
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
 To define, describe, and forecast the global smart pills market on the basis of applications and
regions
 To provide detailed information regarding the major factors influencing the growth of the market
(drivers, restraints, opportunities, industry-specific challenges, winning imperatives, and burning
issues)
 To identify the key micromarkets1 and their drivers within the global smart pills market, which
are expected to show impressive growth in the coming years
 To strategically analyze the market in terms of applications and regions
 To identify the market trends, gaps, and opportunities for all stakeholders
 To strategically analyze the market structure and profile the key players of the global smart pills
market and comprehensively analyze their core competencies2
 To track and analyze competitive developments such as partnerships, joint ventures, mergers
and acquisitions, client acquisitions, new product developments, and marketing and promotion
activities
1.2 MARKET DEFINITION
The smart pills technology [also known as ingestible capsule technology (ICT)] incorporates
miniaturized microelectronic systems in a single chip, which is enclosed in a small capsule. The
capsule is administered orally for diverse diagnostic and biomedical applications.
___________
1. Micromarkets are defined as the further segments and subsegments of the global smart pills market included in the report.
2. Core competencies of companies are captured in terms of the key developments, SWOT analyses, and key strategies adopted by them to
sustain their positions in the market.

13
1.3 MARKET SCOPE
The smart pills technology uses diverse software and hardware systems in a microchip or miniature
semiconductor chip, incorporated in a tiny drug-containing capsule (smaller than a vitamin tablet). This
enables active patient monitoring, accurate site-specific drug delivery, and better image management. The
market is categorized into capsule endoscopy, drug delivery systems, and patient monitoring, depending
on its applications.
The scope of the smart pills market for this study is given below:
 The market study covers various medical applications such as capsule endoscopy, drug
delivery, and patient monitoring for arriving at the global smart pills market size from 2012 to
2024
 Drugs and other medications that enhance the functioning of the brain are not a part of this
study
1.3.1 MARKETS COVERED
This research report categorizes the smart pills market into the following segments:
FIGURE 1 SMART PILLS MARKET SEGMENTATION
Note: Others refer to upper gastro-intestinal area such as esophagus, stomach and duodenum.
Smart Pills Market, by Application
 Capsule Endoscopy
 Small Intestine
 Colon
 Others
 Drug Delivery
 Patient Monitoring
SMART PILLS MARKET
BY TARGET AREA
Small Intestine
Colon
Others
BY APPLICATION
Capsule Endoscopy
Drug Delivery
Patient Monitoring
BY REGION
North America
Europe
Asia
RoW

14
Smart Pills Market, by Region
 North America
 U.S.
 Canada
 Europe
 U.K.
 Germany
 France
 Italy
 Spain
 Rest of Europe (RoE)
 Asia
 Japan
 China
 India
 Rest of Asia (RoA)
 Rest of the World (RoW)
1.3.2 YEARS CONSIDERED FOR THE STUDY
 Historical Years: 2012 and 2013
 Base Year: 2014
 Forecast Year: 2024
Note: For market estimates, the calendar year has been considered; whereas, for company profiles, the fiscal year has been
considered.
1.4 CURRENCY & PRICING
 The currency used in the report is USD, with market sizes indicated in $million.
 For companies reporting their revenues in USD, the revenues were taken from their annual
reports
 For companies that reported their revenues in other currencies, the average annual currency
conversion rate was used for that particular year to convert the value to USD
1.5 LIMITATIONS
 Some of the companies in this market are privately owned and their revenues are not available
in the public domain. Hence, revenues for those companies are not included in this report
 The company developments not reported in the public domain are not included in the report

15
1.6 STAKEHOLDERS
 Pharmaceutical companies
 Healthcare providers (physician practices, diagnostic centers, and outpatient clinics)
 Government bodies
 Corporate entities

16
2 RESEARCH METHODOLOGY
This research study involved the extensive usage of secondary sources, directories, and databases, such
as Hoovers, Bloomberg Businessweek, Factiva, and OneSource, to identify and collect information useful
for this technical, market-oriented, and commercial study of the global smart pills market. Primary sources
are mainly several industry experts from core and related industries, distributors, technology developers,
doctors, alliances, standards and certification organizations from companies, and organizations related to
all segments of this industry’s value chain. In-depth interviews were conducted with various primary
respondents, which include key industry participants, subject matter experts (SMEs), C-level executives of
key market players, and industry consultants, among other experts, to obtain and verify critical qualitative
and quantitative information as well as to assess the future growth prospects.
FIGURE 2 RESEARCH METHODOLOGY DESIGN
• Market classification for the overall smart pills market
• Technical information on smart pills
• Applications of smart pills
• Available products in the market
• Key players in the smart pills market
• Technological developments
• Annual reports, SEC filings/investor presentations, and press releases
of the key industry players
Secondary
Research
• Smart pills market size
• Validation of market drivers, restraints, and opportunities
• Regional markets with their respective market shares
• Market trends and forecast
• Value validation
• Smart pills market segmentation
• Top-down approach
• Bottom-up approach
• Data triangulation
• Market estimates
• Market forecast
• Qualitative and quantitative analysis
Primary
Research
Market
Breakdown

17
2.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.1.1 SECONDARY RESEARCH
Secondary sources were used to identify and collect useful information for this extensive, technical, and
commercial study of the global smart pills market.
2.1.2 KEY DATA FROM SECONDARY SOURCES
This information was used to gauge the technical, market-oriented, and commercial aspects of the smart
pills market.
List of non-exclusive secondary sources:
Associations/Organizations/Institutes:
Press Releases, American Society for Gastrointestinal Endoscopy (ASGE), Society of Gastroenterology
Nurses and Associates (SGNA), European Society of Gastrointestinal Endoscopy (ESGE), Society of
American Gastrointestinal and Endoscopic Surgeons (SAGES), American Gastroenterological Association
(AGA), European Society for Gynaecological Endoscopy (ESGE), European Society of Gastroenterology and
Endoscopy Nurses and Associates (ESGENA), Canadian Association of Gastroenterology (CAG), Hong Kong
Society of Digestive Endoscopy (HKSDE), American Association for Primary Care Endoscopy (AAPCE), Texas
Society for Gastroenterology and Endoscopy (TSGE), World Endoscopy Organization (WEO),
Gastroenterology Society of Australia (GESA), International Society for Gynecologic Endoscopy (ISGE),
Belgian Society of Gastrointestinal Endoscopy (BSGE), Society of Gastrointestinal Endoscopy of India
(SGEI), Asia-Pacific Association for Gynecologic Endoscopy and Minimally Invasive Therapy (APAGE), British
Society of Gastroenterology (BSG), British Society for Gynaecological Endoscopy, Australasian
Gynaecological Endoscopy & Surgery (AGES), International Federation of Societies of Endoscopic Surgeons
(IFSES), and Society of Laparoendoscopic Surgeons.
PARAMETER SECONDARY SOURCES
Market Size
• Company Financials
• Magazines
• Journals
• Press Releases
• Paid Databases
• MarketsandMarkets Data Repository
Revenue
of Companies
• Annual Reports
• Company Websites
• Public Databases
Qualitative Information
(Market Dynamics and Trends)
• Company Websites
• Annual Reports
• Press Releases

18
The secondary research involved three major activities:
Background Study
 To build a basic understanding for the applications of smart pills in capsule endoscopy, drug
delivery, and patient monitoring
 To analyze the MarketsandMarkets data repository as well as to prepare and update the data
tables by using current information
 To identify the data gaps and key players in each of the segments
Market Understanding
 To identify the stakeholders and key decision-makers in different regions
 To identify the selection criteria of key decision-makers
 To analyze the competitive landscape
 Major players with their product portfolios
 Strategies adopted by players to position their products
 To analyze the regional markets
Trends
 To identify and analyze the key products and trends so as to draw notes and include the
consideration in the final forecasts
 To identify the major drivers, restraints, and opportunities prevailing in the market
2.1.3 PRIMARY RESEARCH
Industry experts such as CEOs, presidents, vice presidents, directors, marketing directors, marketing
managers, and related key executives from various key companies and organizations in the smart pills
industry were interviewed to obtain and verify both the qualitative and quantitative aspects of this research
study.
 A robust primary research methodology has been adopted to validate the contents of this report
 Interviews were conducted through e-mails and telephonic calls (questionnaires were designed
and sent to primary participants as per their convenience)

19
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION
Note: *Others include sales managers, marketing managers, and product managers.
Company categorization according to revenues: Tier 1 (Revenue: 1 billion+), Tier 2 (Revenue: 300 million to 1 billion), and Tier 3
(Revenue: less than 300 million)
2.1.3.1 Key data from primary sources
32.5%
47.5%
20%
Tier 1 Tier 2 Tier 3
32%
28%
40%
C-level Director-level Others
42%
25%
18%
15%
North America Europe
Asia RoW
NUMBER OF PRIMARIES:
BY COMPANY TYPE
BY DESIGNATION
BY REGION
PARAMETERTYPES
• Overall market and subsegments in
2024
• CAGR of each region in the forecast
period (2014–2024)
Regional Split
• The global market size
for 2014
• CAGR for the forecast period
(2014–2024)
Global
Market Size
DATA
 The global smart pills
market, by geography –
North America, Europe,
Asia, and RoW
 Global smart pills market
 Smart pills market,
by segment
 Smart pills market,
by application
• Capsule Endoscopy, Drug Delivery,
Patient Monitoring
• Capsule Endoscopy , by target area-
Small Intestine, Colon, others
Market
Split

20
2.1.3.2 Key insights from prim ary sources
Note: The market values have been rounded off till the second decimal. Due to this, there may be a slight difference in the actual
total and the totals mentioned in the tables.
2.2 MARKET SIZE ESTIMATION METHODOLOGY
Both top-down and bottom-up approaches were used to estimate and validate the size of the global market
and to estimate the size of various other dependent submarkets in the overall smart pills market. All
percentage shares, splits, and breakdowns were determined by using secondary sources and verified
through primary sources. All the possible parameters that affect the markets covered in this research study
have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get
the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and
analysis from MarketsandMarkets, and presented in this report.
The following figure shows the overall market size estimation process employed for the purpose of this
study.
Global Smart Pills Market,
by Region
PARAMETERS KEY INSIGHT
Global Smart Pills Market
The adoption of smart pills technology is increasing mainly due to its
noninvasive nature and increased efficiency. Nations across the globe
are striving to enhance the adoption of smart pills technology through
R&D investments and approvals. This has been driving the smart pills
market for capsule endoscopy, drug delivery, and patient monitoring
North America accounted for the largest share of 61.5% in 2014 and is
expected to grow at a CAGR of 17% from 2014 to 2020, owing to the
increased awareness regarding the benefits of smart pills technology
and the need to improve efficiencies in the highly competitive
healthcare market
Drivers and Restraints of the
Market
• Favorable reimbursement scenario, patient preference for
noninvasive procedures, increased incidences of colon cancer,
and rising aging population are the factors driving the market
• Although smart pills technology is considered immensely
beneficial for the healthcare market, primary sources indicated
that increased sophistication will lead to increased cost and
technological incompetence

21
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
All percentage shares, splits, and breakdowns were determined by using secondary sources and verified
through primary sources. All the possible parameters that affect the markets covered in this research study
Calculation
of the market
to 100%
Mapping company-
wise revenues to the
extent of 85% of the
market covered
Mapping the company-wise
revenue generated through sales
of products (smart pills)
Generating a list of players operating in the
smart pills market
PRIMARY SOURCES:
Demand and Supply Side Experts
SECONDARY SOURCES:
Annual Reports, Presentations,
Press Release, Journals, Paid
Databases, and
MarketsandMarkets Repository
Total Smart Pills Market ($Million)
Percentage Split of the Market by
Application (Capsule Endoscopy, Drug
Delivery, and Patient Monitoring)
The Global Market Size is Validated Through Primaries
(Demand and Supply Side Experts)
PRIMARY SOURCES:
Demand and Supply Side Experts
SECONDARY SOURCES:
Annual Reports, Presentations, Press
Release, Journals, Paid Databases, Company
Websites, News Articles, and
MarketsandMarkets Repository
Regional Split
Regional
Market for
Each
Subsegment

22
have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get
the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and
analysis from MarketsandMarkets.
2.2.1 MARKET FORECAST METHODOLOGY
FIGURE 6 MARKET FORECAST METHODOLOGY
2.2.2 MARKET DATA VALIDATION AND TRIANGULATION
In order to complete the overall market engineering process and to arrive at the exact statistics for all the
market segments and subsegments, the data triangulation and validation procedures explained below
were implemented, wherever applicable.
HISTORICAL DATA
FOR THE SMART
PILLS MARKET
INFLUENCING
FACTORS
(Market Trends and
Dynamics)
Historical Data of the
Market
Market Size & Forecast, by Application
Arrive at the Market
Size, Share, and CAGR
for the Smart Pills
MarketImpact Analysis of
Market Trends
FORECAST
MARKET DRIVERS:
• Favorable
reimbursement
scenario
• Patient preference for
minimally invasive
surgeries
• Increased incidences of
colon cancer
Investments by Companies
MARKET RESTRAINTS:
• Technological
incompetence of
capsule endoscopes
• Increasing
sophistication to
increase the smart pills
cost
MARKET OPPORTUNITIES:
• Rapid drug
development
processes
REGIONAL ANALYSIS:
Market Dynamics and Business Environment in North America, Europe, Asia, and Rest
of the World (RoW: Pacific Countries, Africa, Middle East,
and Latin America)
• Agreements, Collaborations, and Partnerships:
Accounted for 52.2% of total strategies adopted
• New Product Launches: Accounted for 21% of the total
strategies adopted
Market Size & Forecast, by Region
Smart Pills
Technology
Adoption
Technology Trends Company Revenues
Regulatory
Landscape
Business Trends
Competitive
Landscape
Regional Usage
Pattern

23
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.2.3 ASSUMPTIONS FOR THE STUDY
MnM KNOW* stands for MarketsandMarkets’ 'Knowledge Asset Management' framework. In this context, it stands for
an existing market research knowledge repository of over 5,000 granular markets, our flagship competitive intelligence and
market research platform "RT", subject matter experts, and independent consultants. MnM KNOW acts as an independent
source that helps us validate information gathered from primary and secondary sources .
SECONDARYSOURCESPRIMARY SOURCES
• The American Society for
Gastrointestinal
Endoscopy(ASGE)
• Agency for Healthcare Research
and Quality (AHRQ)
• The World Endoscopy
Organisation (WEO)
Annual Reports, Presentations,
Websites and Press Releases
of Top Players, News Articles,
Journals, and Paid Databases
Interviews with:
• Physicians
• Gastroenterologists
• Surgeons
DEMANDSIDE
Interviews with:
• Presidents, CEOs, Vice
Presidents, Directors, and
Senior Managers
• Product/Sales/Marketing
Specialists and Business
Intelligence Consultants
SUPPLYSIDE
INFORMATIONSOURCED
Key Players Competitive Landscape
Drivers/Restraints
Opportunities/Challenges
Forecasting
Market Size (2014)
and Market Share
(2014)
Region-wise Analysis
MnM KNOW*
PRIMARY
SOURCE
SECONDARY
SOURCE
DATA
TRIANGULATION
General Assumptions
PARAMETERS ASSUMPTIONS
• There will be no drastic changes in the market scenario during the
forecast period
• There will be no changes in regulations that have a huge impact
on the industry
• Many smart pill products will be launched in the market in the
coming years. These products are expected to reach the market
by 2020. Hence, two growth rates—2014 to 2020 and 2020 to
2024—are considered for this report.

24
SAMPLE TABLES
TABLE 1 GERMANY: SMART PILLS MARKET SIZE, BY APPLICATION, 2012–2024 ($MILLION)
Application 2012 2013 2014 2020 2024
CAGR%
(2014–2020)
CAGR%
(2020–2024)
Capsule Endoscopy XX XX XX XX XX XX XX
Drug Delivery XX XX XX XX XX XX XX
Patient Monitoring XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX
Source: Annual Reports, Press Releases, International Federation of Societies of Endoscopic Surgeons, American Society for
Gastrointestinal Endoscopy, European Society of Gastrointestinal Endoscopy, Asia-Pacific Association for Gynecologic Endoscopy and
Minimally Invasive Therapy (APAGE), Centers for Disease Control and Prevention (CDC), Expert Interviews, and MarketsandMarkets
Analysis
TABLE 2 ASIA: CAPSULE ENDOSCOPY MARKET SIZE, BY TARGET AREA, 2012–2024 ($MILLION)
Target Area 2012 2013 2014 2020 2024
CAGR%
(2014–2020)
CAGR%
(2020–2024)
Small Intestine XX XX XX XX XX XX XX
Colon XX XX XX XX XX XX XX
Others XX XX XX XX XX XX XX
Analysis
TABLE 3 PACIFIC COUNTRIES: SMART PILLS MARKET SIZE, BY APPLICATION,
2012–2024 ($MILLION)
Application 2012 2013 2014 2020 2024
CAGR%
(2014–2020)
CAGR%
(2020–2024)
Capsule Endoscopy XX XX XX XX XX XX XX
Drug Delivery XX XX XX XX XX XX XX
Patient Monitoring XX XX XX XX XX XX XX
Analysis

25
RELATED REPORTS
Report Title Published Date
1
Injectable Drug Delivery Market
by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables &
Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes
& Oncology] - Global Forecasts to 2017
http://www.marketsandmarkets.com/Market-Reports/injectable-drug-delivery-market-
150.html
April 2013
2
Drug Delivery Technologies Market
(Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal
Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular
Implants) - Global Forecasts To 2017
http://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-
1085.html
April 2013

26
Disclaimer: MarketsandMarkets strategic analysis services are limited publications containing valuable
market information provided to a select group of customers in response to orders. Our customers
acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customers’
internal use and not for general publication or disclosure to third parties. Quantitative market information is
based primarily on interviews and therefore, is subject to fluctuation.
MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications.
MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets' research
and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed
or implied, with respect to this research, including any warranties of merchantability or fitness for a particular
purpose.
MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or
users.
All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may
be protected by copyright. Under no circumstance may any of these be reproduced in any form without the
prior written agreement of their owner.
No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without
written permission.
Reproduction and/or transmission in any form and by any means including photocopying, mechanical,
electronic, recording or otherwise, without the permission of the publisher is prohibited.
For information regarding permission, contact:
Tel: 1-888-600-6441
Email: sales@marketsandmarkets.com

The Global Smart Pills Market is segmented on the basis of applications and regions.

Recommended

Recommended

More Related Content

Similar to The Global Smart Pills Market is segmented on the basis of applications and regions.

Similar to The Global Smart Pills Market is segmented on the basis of applications and regions. (20)

Recently uploaded

Recently uploaded (20)

The Global Smart Pills Market is segmented on the basis of applications and regions.